Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash from Investing Activities: 2013-2024

Historic Cash from Investing Activities for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to -$1.9 million.

  • Armata Pharmaceuticals' Cash from Investing Activities fell 2872.22% to -$535,000 in Q4 2018 from the same period last year, while for Dec 2018 it was -$597,000, marking a year-over-year decrease of 929.31%. This contributed to the annual value of -$1.9 million for FY2024, which is 76.90% up from last year.
  • As of FY2024, Armata Pharmaceuticals' Cash from Investing Activities stood at -$1.9 million, which was up 76.90% from -$8.1 million recorded in FY2023.
  • In the past 5 years, Armata Pharmaceuticals' Cash from Investing Activities ranged from a high of -$824,000 in FY2020 and a low of -$8.1 million during FY2023.
  • For the 3-year period, Armata Pharmaceuticals' Cash from Investing Activities averaged around -$4.1 million, with its median value being -$2.2 million (2022).
  • In the last 5 years, Armata Pharmaceuticals' Cash from Investing Activities plummeted by 267.89% in 2023 and then soared by 76.90% in 2024.
  • Armata Pharmaceuticals' Cash from Investing Activities (Yearly) stood at -$824,000 in 2020, then crashed by 58.25% to -$1.3 million in 2021, then tumbled by 69.56% to -$2.2 million in 2022, then plummeted by 267.89% to -$8.1 million in 2023, then skyrocketed by 76.90% to -$1.9 million in 2024.